Presentation is loading. Please wait.

Presentation is loading. Please wait.

Acute Kidney Injury (AKI)

Similar presentations


Presentation on theme: "Acute Kidney Injury (AKI)"— Presentation transcript:

1 Acute Kidney Injury (AKI)
The Clinical Aspects & Medicines Involved Kate Webb Renal Advanced Pharmacist Practitioner University Hospital of North Midlands UK Renal Pharmacy Group

2 Learning Objectives Understand what is AKI?
Understand the clinical issues associated with AKI?

3 Summary of Presentation
Renal Anatomy + Physiology AKI Definition Etiology Outcomes Goals Case Study Conclusion

4 Renal Anatomy

5 Renal Physiology Regulation of water & electrolytes
Retention of substances i.e. protein / glucose Excretion of waste, H2O soluble & drug products Acid / base balance Endocrine function: - Renin, Aldosterone, ADH Erythropoeitin, Vitamin D

6 AKI Definition: ‘Abrupt ↓ in kidney function that includes, but is not limited to, Acute Renal failure.’ Various etiologies Kidney diseases (nephritis, vasculitis) Non-specific conditions (ischaemia) Extrarenal pathology (post-renal obstruction)

7 AKI – Outcomes & Goals Outcomes: - Significant mortality & morbidity
Prevent further damage Facilitate recovery of renal function “20-30% AKI is predictable & avoidable”

8 AKI – Prevent further damage
Identify the cause for AKI asap Avoid nephrotoxic meds Aminoglycosides, Amphotericin, NSAIDs Avoid nephrotoxic procedures U/S with contrast Consider ‘drug holidays’ ACEIs, ARBs

9 AKI – Facilitate recovery of Renal function
Identify pts who need dialysis vs. medical management Give fluids (1.5l – 2l /day) Crystalloids vs. Colloids vs. Blood Treat cause e.g. drug toxicity Regular monitoring Avoid hyperglycemia

10 AKI – Classification & Alerts
AKI Stage Creatinine Criteria Urine Output Criteria Predicted Nos / year of AKI in bedded hospital One ↑ > 26mmol/l above baseline (within 48hrs) OR ↑ > 1.5 fold from baseline < 0.5ml/kg/hr for at least 6 hrs 2727 Two ↑ > 2.0 fold from baseline < 0.5ml/kg/hr for at least 12 hrs 782 Three ↑ > 3.0 fold from baseline AKI with Cr > 354mmol/l Initiation of Renal Replacement Therapy (RRT) < 0.3ml/kg/hr for at least 24 hrs Anuria > 12hrs 636 Total 4145

11 AKI – Case Study ♂, 34yrs. PC  Collapsed. GCS 12. On admission, Bp 54/30, Tachycardic, Resp Rate > 35, Temp 39.6 PMH  Asthma DHx  Beclomethasone Inh + Salbutamol Inh Implication  Systemic sepsis ? cause

12 AKI – Case Study Biochemistry:
Na+ = 138 K+ = Urea = 56.2 Cr = 784 eGFR = 11 CRP = 160 Hb = 126 WBC = Plts = 156 Alb = 39 Calcium = 2.2 Phosphate = 1.3

13 AKI – Case Study Biochemistry:
Na+ = K+ = 7.2(High) Urea = 56.2 (High) Cr = 784 (High) eGFR = 11 (Low) CRP = 160 (High) Hb = WBC = 33.6 (High) Plts = Alb = 39 Calcium = 2.2 Phosphate = 1.3

14 AKI – Classification & Alerts
AKI Stage Creatinine Criteria Urine Output Criteria Predicted Nos / year of AKI in bedded hospital One ↑ > 26mmol/l above baseline (within 48hrs) OR ↑ > 1.5 fold from baseline < 0.5ml/kg/hr for at least 6 hrs 2727 Two ↑ > 2.0 fold from baseline < 0.5ml/kg/hr for at least 12 hrs 782 Three ↑ > 3.0 fold from baseline AKI with Cr > 354mmol/l Initiation of Renal Replacement Therapy (RRT) < 0.3ml/kg/hr for at least 24 hrs Anuria > 12hrs 636 Total 4145

15 AKI – Case Study CXR  R + L sided consolidation
Pneumonia (? Microbiology) Hypoxic + Acidotic Ventilated (Level 3 care) Urine Output  12ml/hr, 5ml/hr, 6ml/hr (Pt wt = 80kg) Filter (Level 3 care)  CVVHDF

16 AKI – Classification & Alerts
AKI Stage Creatinine Criteria Urine Output Criteria Predicted Nos / year of AKI in bedded hospital One ↑ > 26mmol/l above baseline (within 48hrs) OR ↑ > 1.5 fold from baseline < 0.5ml/kg/hr for at least 6 hrs 2727 Two ↑ > 2.0 fold from baseline < 0.5ml/kg/hr for at least 12 hrs 782 Three ↑ > 3.0 fold from baseline AKI with Cr > 354mmol/l Initiation of Renal Replacement Therapy (RRT) < 0.3ml/kg/hr for at least 24 hrs Anuria > 12hrs 636 Total 4145

17 AKI – Case Study Pneumonia  Abx broad + empirical
Co-Amoxiclav + Clarithromycin Ventilated  Sedated Morphine + Midazolam vs. Alfentanyl + Propofol CVVHDF Effects on drug dosing / Clotting / Dialysis fluids Fluids  ? Give / Type Others  VAP meds / GI protection / TEDs

18 AKI – Case Study 11 Days later….. U&Es: -
Na+ = 138 K+ = 4.3 Urea = 11.2 (High) Cr = 284 (High) eGFR = 32 (Low) CRP = 32 (High) Hb = 126 WBC = 13.6 (High) Urine Output: - 42ml/hr, 54ml/hr, 47ml/hr Pt Discharged Meds: - Co-Amoxiclax 625mg TDS for 4 days Clarithromycin 500mg BD for 4 days Paracetamol 1gram QDS PRN Becotide® 100 ii puffs BD Salbutamol 100 PRN

19 Conclusion Renal Anatomy + Physiology Understanding of AKI
AKI  Prevent further damage  Facilitate recovery AKI application in Practice

20 Questions


Download ppt "Acute Kidney Injury (AKI)"

Similar presentations


Ads by Google